Xenon Pharmaceuticals Target Price

Where could XENE trade next? Consensus target price: $76.

Get informed when a big investor buys or sells

+ Follow

Share Price

$63.18

Average Target Price

$75.50

19.5% upside

4 analysts in the last 4 months

High: $81 | Low: $69

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

Date	Analyst	Price Target	Current Upside/Downside
2026-08-10	H.C. WainwrightDouglas Tsao	$74	17.1% upside
2026-08-07	RBC CapitalBrian Abrahams	$81	28.2% upside
2026-05-10	Wells FargoBenjamin Burnett	$69	9.2% upside
2026-05-08	NeedhamSerge Belanger	$78	23.5% upside
2026-03-10	Deutsche Bank	$90	42.5% upside
2026-03-09	RBC Capital	$80	26.6% upside
2026-03-09	JefferiesAndrew Tsai	$100	58.3% upside
2026-03-09	GuggenheimYatin Suneja	$90	42.5% upside
2026-03-09	Morgan Stanley	$97	53.5% upside
2026-03-09	Robert W. Baird	$97	53.5% upside
2026-03-09	Stifel NicolausPaul Matteis	$89	40.9% upside
2026-03-09	JefferiesAndrew Tsai	$65	2.9% upside
2026-02-23	Wolfe Research	$60	5% downside
2026-02-10	Stifel Nicolaus	$66	4.5% upside
2025-11-04	RBC Capital	$58	8.2% downside
2025-11-04	Cantor FitzgeraldJosh Schimmer	$55	12.9% downside
2025-11-04	Wells FargoBenjamin Burnett	$44	30.4% downside
2025-02-28	Wedbush	$42	33.5% downside
2024-10-10	Raymond JamesDanielle Brill	$50	20.9% downside
2024-10-01	H.C. WainwrightDouglas Tsao	$53	16.1% downside
2024-08-09	WedbushLaura Chico	$49	22.4% downside
2024-06-18	RBC CapitalBrian Abrahams	$55	12.9% downside
2022-12-14	Goldman Sachs	$60	5% downside
2022-11-28	Wells Fargo	$50	20.9% downside
2022-11-11	Guggenheim	$49	22.4% downside
2022-10-18	Raymond JamesDanielle Brill	$52	17.7% downside
2022-08-11	Leerink Partners	$46	27.2% downside
2022-08-10	RBC Capital	$46	27.2% downside
2022-06-27	Wedbush	$41	35.1% downside
2022-05-11	RBC Capital	$41	35.1% downside

Xenon Pharmaceuticals (XENE) FAQ

Xenon Pharmaceuticals posts a target price of $76. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

A target price of $76 for XENE means covering analysts, on average, see the stock 19.5% upside of $63.18 over about 12 months. Dig into who set the high and low targets and how recently they updated — freshness matters as much as the average itself.

Context for XENE's target price usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Xenon Pharmaceuticals's other metric pages and overview cover the third.

Judging Xenon Pharmaceuticals against Healthcare peers is usually better than using a market-wide rule of thumb. Business models inside Healthcare are more comparable, which makes gaps in target price easier to interpret. Start with $76 here, then scan peer and history charts to see if the gap is persistent.